What is the best form of nutrition support during an Allogeneic Transplant

Recruiting

• Conditions: Allogeneic transplants; Nutrition support; Cancer - Leukaemia - Acute leukaemia; Cancer - Leukaemia - Chronic leukaemia; Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma

• Registration Number: ACTRN12611001084976
• Lead Sponsor: A/Prof Glen Kennedy

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-10-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

Inclusion criteria include: Patients undertaking allogeneic transplants, aged >18 and <65 years and have an ability to understand and willingness to sign a written informed consent document.

Exclusion Criteria

Exclusion criteria include: Known anatomic deformity preventing nasogastric tube insertion, non-functional and / or inaccessible gastrointestinal tract to enteral feeding when feeding is required, as defined by presence of Grade 3-4 mucositis or intestinal ileus or intractable vomiting.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is tolerance of route of supplemental feeding. Tolerance of route of supplemental nutritional support is defined as <30% of patients needing to change to the alternative route of support for any reason.[The primary outcome is measured throughout the period of supplementary feeding.]